Neurocrine Biosciences, Inc(NASDAQ:NBIX) 
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tar...
Website: http://www.neurocrine.com
Founded: 1992
Full Time Employees: 825
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 99.40
H 100.37
L 93.59
C 95.65
V 2,452,044
10EMA 95.65
20EMA 95.65
60EMA 95.65
120EMA 95.65
250EMA 95.65